Evidence map›Paper›PMID 36586607›Full record

Trial reportJournal of affective disorders2023

Comparing depression screening tools (CESD-10, EPDS, PHQ-9, and PHQ-2) for diagnostic performance and epidemiologic associations among postpartum Kenyan women: Implications for research and practice.

Anna Larsen, Jillian Pintye, Ben Odhiambo, Nancy Mwongeli, Mary M Marwa, Salphine Watoyi, John Kinuthia, Felix Abuna, Laurén Gomez, Julia Dettinger and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of affective disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Anna LarsenUniversity of Washington, Department of Epidemiology, United States of America. Electronic address: annalar@uw.edu.
Jillian PintyeUniversity of Washington, Department of Global Health, United States of America.
Ben OdhiamboUniversity of Nairobi/Kenyatta National Hospital, Kenya.
Nancy MwongeliUniversity of Nairobi/Kenyatta National Hospital, Kenya.
Mary M MarwaUniversity of Nairobi/Kenyatta National Hospital, Kenya.
Salphine WatoyiUniversity of Nairobi/Kenyatta National Hospital, Kenya.
John KinuthiaUniversity of Nairobi/Kenyatta National Hospital, Kenya.
Felix AbunaUniversity of Nairobi/Kenyatta National Hospital, Kenya.
Laurén GomezUniversity of Washington, Department of Global Health, United States of America.
Julia DettingerUniversity of Washington, Department of Global Health, United States of America.
Amritha BhatUniversity of Washington, Department of Psychiatry and Behavioral Sciences, United States of America.
Grace John-StewartUniversity of Washington, Department of Epidemiology, United States of America; University of Washington, Department of Global Health, United States of America; University of Washington, Department of Medicine, United States of America; University of Washington, Department of Pediatrics, United States of America.
University of Washington · USKenyatta National Hospital · KEUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Delivering PrEP in PregnancyR01AI125498 · NIAID · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2016 to 2020
$3.6M
Evaluating Infant PrEP Exposure During Pregnancy and BreastfeedingR01HD100201 · NICHD · UNIVERSITY OF WASHINGTON · PI PINTYE, JILLIAN · 2019 to 2023
$3.4M
PrEP optimized for mothers (PrOM): efficient PrEP integration in MCH clinicsR01HD094630 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C., KOHLER, PAMELA · 2017 to 2021
$3.3M
Evaluating perinatal mood and anxiety disorder in Kenyan: a mixed methods approachF32HD108857 · NICHD · UNIVERSITY OF WASHINGTON · PI LARSEN, ANNA M · 2022 to 2023
$144k
Evaluating maternal depression among adolescent and adult women in KenyaF31HD101149 · NICHD · UNIVERSITY OF WASHINGTON · PI LARSEN, ANNA M · 2019 to 2022
$125k
NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI125498NICHD NIH HHS F31 HD101149NICHD NIH HHS F32 HD108857NICHD NIH HHS R01 HD094630NICHD NIH HHS R01 HD100201
6 · The paper itself

Abstract

backgroundIdentifying optimal depression screening tools for use in maternal health clinics could improve maternal and infant health. We compared four tools for diagnostic performance and epidemiologic associations.

methodsThis study was nested in a cluster-randomized trial in Kenya. Women in 20 maternal health clinics were evaluated at 6 weeks postpartum with Center for Epidemiologic Studies Depression Scale (CESD-10), Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 and -2 (PHQ-9, PHQ-2) for moderate-to-severe depressive symptoms (MSD) [CESD-10 ≥ 10, EPDS≥13, PHQ-9 ≥ 10, or PHQ-2 ≥ 3]. We assessed area under the curve (AUC) per scale (CESD-10, EPDS) against probable major depressive disorder (MDD) using the PHQ-9 scoring algorithm. Associations between MSD and intimate partner violence (IPV) were compared between scales.

resultsAmong 3605 women, median age was 24 and 10 % experienced IPV. Prevalence of MSD symptoms varied by tool: 13 % CESD-10, 9 % EPDS, 5 % PHQ-2, 3 % PHQ-9. Compared to probable MDD, the CESD-10 (AUC:0.82) had higher AUC than the EPDS (AUC:0.75). IPV was associated with MSD using all scales: EPDS (RR:2.5, 95%CI:1.7-3.7), PHQ-2 (RR:2.3, 95%CI:1.6-3.4), CESD-10 (RR:1.9, 95%CI:1.2-2.9), PHQ-9 (RR:1.8, 95%CI:0.8-3.8). LIMITATIONS: Our study did not include clinical diagnosis of MDD by a specialized clinician, instead we used provisional diagnosis of probable MDD classified by the PHQ-9 algorithm as a reference standard in diagnostic performance evaluations.

conclusionDepression screening tools varied in detection of postpartum MSD. The PHQ-2 would prompt fewer referrals and showed strong epidemiologic association with a cofactor.

Indexed as

Depression, PostpartumMajor Depressive DisorderDepressionFemaleHumansKenyaMass ScreeningPatient Health QuestionnairePostpartum PeriodPsychiatric Status Rating ScalesSurveys and QuestionnairesCESD-10EPDSPHQ-2PHQ-9Postpartum depressionScreeningSub-Saharan Africa

Identifiers

PMID36586607
PMCPMC9990497
OpenAlexW4313379843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.